Literature DB >> 30001929

Novel mutations in HINT1 gene cause autosomal recessive axonal neuropathy with neuromyotonia in two cases of sensorimotor neuropathy and one case of motor neuropathy.

Lingchao Meng1, Jun Fu1, He Lv1, Wei Zhang1, Zhaoxia Wang1, Yun Yuan2.   

Abstract

Autosomal recessive axonal neuropathy with neuromyotonia (ARANNM) is a rare disease caused by mutations of histidine triad nucleotide binding protein 1 (HINT1) gene. ARANNM has been reported mainly in European countries but little reported so far in China. We describe novel mutations of HINT1 in three Chinese patients with ARANNM from unrelated families. Patient 1 was a 14-year-old girl who presented with progressive distal weakness of upper limbs at two years of age. After that, she reported weakness of both feet, and difficulty in muscle relaxation after making a fist. Patient 2 was an 18-year-old boy, who presented with progressive distal weakness of all limbs with foot drop at the age of ten with loss of ambulation at age 15. Patient 3 was a 26-year-old man who had been afflicted with weakness and atrophy of distal lower limbs since the age of 16 complaining about muscle stiffness of the lower limbs when standing and walking, and contraction of finger flexion muscles when releasing a forced grip. Electrodiagnostic testing revealed an axonal motor or sensorimotor neuropathy with or without myokymic discharges. Sural biopsy showed no pathological changes in patient 1 and mild axonal neuropathies with demyelination in patients 2 and 3. Genetic analysis revealed HINT1 with novel compound heterozygous c.112T > C (p.C38R) and c.171G > C (p.K57N) mutations in patient 1, homozygous c.112T > C (p.C38R) mutation in patient 2, as well as compound heterozygous c.112T > C (p.C38R) and c.98T > C (p.F33S) mutations in patient 3. Our study, for the first time, confirms ARANNM in the Chinese population. These genetic findings can help expand the genotypic spectrum of HINT1 mutations.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HINT1; Hereditary neuropathy; Neuromyotonia

Mesh:

Substances:

Year:  2018        PMID: 30001929     DOI: 10.1016/j.nmd.2018.05.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  The Axonal Motor Neuropathy-Related HINT1 Protein Is a Zinc- and Calmodulin-Regulated Cysteine SUMO Protease.

Authors:  Elsa Cortés-Montero; María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Javier Garzón
Journal:  Antioxid Redox Signal       Date:  2019-06-24       Impact factor: 8.401

2.  HINT1 neuropathy in Norway: clinical, genetic and functional profiling.

Authors:  Silvia Amor-Barris; Helle Høyer; Albena Jordanova; Geir J Braathen; Kristien Peeters; Lin V Brauteset; Els De Vriendt; Linda Strand
Journal:  Orphanet J Rare Dis       Date:  2021-03-04       Impact factor: 4.123

3.  Myasthenia gravis coexisting with HINT1-related motor axonal neuropathy without neuromyotonia: a case report.

Authors:  Jia Fang; Hui Huang; Qiang Lei; Yingying Luo; Zhengchu Tang; Xiaoliu Shi; Jian Guang Tang
Journal:  BMC Neurol       Date:  2022-05-03       Impact factor: 2.474

4.  HINT1 neuropathy in Lithuania: clinical, genetic, and functional profiling.

Authors:  Matilde Malcorps; Silvia Amor-Barris; Birute Burnyte; Albena Jordanova; Kristien Peeters; Ramune Vilimiene; Camila Armirola-Ricaurte; Kristina Grigalioniene; Alexandra Ekshteyn; Ausra Morkuniene; Arunas Vaitkevicius; Els De Vriendt; Jonathan Baets; Steven S Scherer; Laima Ambrozaityte; Algirdas Utkus
Journal:  Orphanet J Rare Dis       Date:  2022-10-14       Impact factor: 4.303

5.  Rare among Rare: Phenotypes of Uncommon CMT Genotypes.

Authors:  Luca Gentile; Massimo Russo; Federica Taioli; Moreno Ferrarini; M'Hammed Aguennouz; Carmelo Rodolico; Antonio Toscano; Gian Maria Fabrizi; Anna Mazzeo
Journal:  Brain Sci       Date:  2021-12-08

6.  HINT1 founder mutation causing axonal neuropathy with neuromyotonia in South America: A case report.

Authors:  Bianca de Aguiar Coelho Silva Madeiro; Kristien Peeters; Elker Lene Santos de Lima; Silvia Amor-Barris; Els De Vriendt; Albena Jordanova; Maria Tereza Cartaxo Muniz; Carolina da Cunha Correia
Journal:  Mol Genet Genomic Med       Date:  2021-09-25       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.